News and updates from across the LGC Group

Leading manufacturer and supplier of analytical reference standards greatly complements LGC's current offering

After ten years with LGC, initially as Chief Executive Officer and most recently as Non-Executive Chair, Tim Robinson has announced that, as planned, he will be retiring from LGC to focus on public service and philanthropy.

Update for the half year ended 30 September 2022

LGC's first ESG report using GRI Standards, the most widely used sustainability reporting framework

Australians identified by LGC's ongoing DNA work concerning remains discovered at Fromelles, northern France

Roadmap to support the measurements associated with infectious disease and future pandemic readiness has recently been published

Facility will serve as home of The Native Antigen Company and an advanced workflow applications laboratory for LGC Biosearch Technologies

This is LGC’s second ESG report using the Global Reporting Initiative (GRI) Standards, the most widely used sustainability reporting framework globally.

The paper, titled “Monkeypox: another test for PCR”, focuses on how to ensure the PCR diagnosis tests being deployed for monkeypox will be most accurate and that lessons learned on PCR testing from the COVID-19 pandemic are applied to the current epidemic.

The exclusive partnership will also be extended to include the analysis of phenotypic-genotypic correlations and metabolic profiling of some common maternal/ fetal cardiac defects known to be related to monogenic disorders.

Easy-to-use app-based microlearning provides training in a range of cannabis-related topics

Expands LGC’s offering to more than 180 allergen reference materials for a range of applications including method development and method verification